The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Artyushkin S.A.
St. Petersburg Research Institute of Ear, Throat, Nose and Speech;
Mechnikov St. Petersburg State Medical University
Yanov Yu.K.
Mechnikov St. Petersburg State Medical University;
Kirov Military Medical Academy
Ryazantsyev S.V.
St. Petersburg Research Institute of Ear, Throat, Nose and Speech
Eremin S.A.
St. Petersburg Research Institute of Ear, Throat, Nose and Speech
The results of a 5-year clinical and epidemiological study of the National Program “Chronic tonsillitis”
Journal: Russian Bulletin of Otorhinolaryngology. 2024;89(6): 28‑39
Views: 458
Downloaded: 24
To cite this article:
Artyushkin SA, Yanov YuK, Ryazantsyev SV, Eremina NV, Artyushkina VK, Eremin SA. The results of a 5-year clinical and epidemiological study of the National Program “Chronic tonsillitis”. Russian Bulletin of Otorhinolaryngology.
2024;89(6):28‑39. (In Russ.)
https://doi.org/10.17116/otorino20248906128
To study the epidemiological characteristics of chronic tonsillitis (ChT), the need for patients to undergo conservative and surgical treatment, and a comparative assessment of the effectiveness of conservative treatment of patients with chronic tonsillitis using Tonsilotren as monotherapy and in complex treatment. The study involved 999 otorhinolaryngologists from the outpatient network of 20 major Russian cities. The data of 74125 patients diagnosed with ChT were analyzed. A significant predominance of the compensated form of ChT has been established, among the types of decompensation — relapses of acute tonsillitis. The peculiarities of changes in the structure of ChT forms during the period of Sars-CoV-2 coronavirus infection have been established. The expediency of widespread implementation of active measures to identify patients with compensated form of ChT, to perform anti-relapse conservative treatment of ChT using the drug Tonsilotren based on criteria of its effectiveness (IMOS) and tolerability (IMPSS) has been proved.
Keywords:
Authors:
Artyushkin S.A.
St. Petersburg Research Institute of Ear, Throat, Nose and Speech;
Mechnikov St. Petersburg State Medical University
Yanov Yu.K.
Mechnikov St. Petersburg State Medical University;
Kirov Military Medical Academy
Ryazantsyev S.V.
St. Petersburg Research Institute of Ear, Throat, Nose and Speech
Eremin S.A.
St. Petersburg Research Institute of Ear, Throat, Nose and Speech
Received:
17.10.2024
Accepted:
12.11.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.